current glp-1 drugs Chart: 1 in 8 Americans Now Use for Weight Loss What are GLP-1s? | Mendinground

It was not clear how a drug that primarily affects glucose metabolism might directly impact the occurrence of cardiovascular events

A handful of reviewers have been under the impression that they were locked in at discounted rates, but were disappointed when seeing increased charges on their next months bill

And then the question of is there straight chronic weight management in the elderly becomes less important over time? And so, this [reimbursement] will play out over time on both as we look at data and outcomes to drive further expansion of access. I think the affordability aspect is simply a matter of time

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Holst JJ

For patients where cardiovascular protection is the primary concern, both are reasonable choices, though semaglutides data may suggest greater benefit